Duliege Anne-Marie 4
4 · RIGEL PHARMACEUTICALS INC · Filed Apr 24, 2018
Insider Transaction Report
Form 4
Duliege Anne-Marie
Chief Medical Officer
Transactions
- Sale
Common Stock
2018-04-20$4.11/sh−5,000$20,550→ 0 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 26, 2018.
- [F2]The Reporting Person purchased these shares on December 29, 2017 under the Employee Stock Purchase Plan.